The Potential for Targeted Inhibition of Factor XI/XIa to Provide Safe and Effective Protection from a Secondary Ischemic Noncardioembolic Stroke
Is There a Safe and Effective Anticoagulation Strategy for Secondary Prevention of Non-Cardioembolic Ischemic Stroke?
LIVE UPDATE FROM AHA24: What do we know about antiplatelets added to anticoagulation in patients with AF?
Update on Emerging Anticoagulants
Live Tweetorial from ISC24: Predictors of Hematoma Expansion and Response to Andexanet in ANNEXa-I
Journal Club: Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage
Code ICH: A Call to Action
Cancer Associated Thrombosis: Current and Future Treatment Strategies, Assessing Relative Risk Among Cancer Types